Canine
transmissible venereal tumor (CTVT) is a
tumor with low MHC
antigen expression and is an ideal
tumor model for studying the interactions between host immunity and
cancer cells. CTVTs produce high concentrations of
TGF-beta to hamper the host immune responses and facilitate their growth progression. However, during the later stages of
tumor progression, tumor-infiltrating lymphocytes secrete
IL-6. This
cytokine antagonizes
TGF-beta and restores the IFN-gamma activities in promoting MHC
antigen expression, and the NK cytotoxicity that has been repressed by
TGF-beta is also activated. In this study, we applied combinatory treatment of
IL-6 plasmid and
IL-15 plasmid (pIL-6/pIL-15) to CTVT-bearing beagles.
IL-6 was used as an anti-
TGF-beta cytokine;
IL-15 was used to promote NK- and CTVT-specific cytotoxicity. After intratumoral pIL-6/pIL-15 delivery mediated by electroporation, MHC
antigen expression on CTVT cells was dramatically increased from in less than 5.9% to up to 34% of the
tumor cells. The proportion of CD8(+) T cells infiltrating the
tumor was also significantly elevated from 6.96+/-0.23% to 21.63+/-5.40%. In addition, the
tumor-specific cytotoxicity was enhanced along with a marked increase in
tumor-specific IFN-gamma-producing cells. These immune responses are believed to be the important forces driving the
tumor towards regression. The results indicate that pIL-6/pIL-15 combinatory
immunotherapy may facilitate a promising and effective means of treating
tumors.